<DOC>
	<DOCNO>NCT00893789</DOCNO>
	<brief_summary>The primary objective study determine whether armodafinil treatment effective placebo treatment patient excessive sleepiness associate mild moderate close traumatic brain injury ( TBI ) .</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Armodafinil Treatment Patients With Excessive Sleepiness Associated With Mild Moderate Closed Traumatic Brain Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>The patient mild ( Glasgow Coma Scale [ GCS ] score 1315 ) moderate ( GCS score 912 ) close TBI time injury , injury occur 1 10 year prior screen . The patient Glasgow Outcome Scale score 5 screen visit . The patient Epworth Sleepiness Scale ( ESS ) score least 10 screening . The patient mean sleep latency Multiple Sleep Latency Test ( MSLT ) ( average 4 nap ) less 8 minute baseline . The patient Clinical Global Impression Severity Illness ( CGIS ) rating relate excessive sleepiness 4 screen baseline visit . The patient complaint excessive sleepiness ( least 5 days/week average ) least 3 month , excessive sleepiness begin within 12 month TBI . Written inform consent obtain . The patient man woman ethnic origin 18 65 year age . If admit inpatient treatment facility , patient discharge least 1 month prior screen visit . The patient medical psychiatric disorder could account excessive sleepiness . Women childbearing potential ( surgically sterile 2 year postmenopausal ) , use medically accepted method contraception , continue use one method duration study ( 30 day participation study ) . Acceptable method contraception include : abstinence , barrier method spermicide , steroidal contraceptive ( oral , transdermal , implanted , inject ) conjunction barrier method , intrauterine device ( IUD ) . The patient otherwise good health , judge investigator , basis medical psychiatric history , physical examination , electrocardiogram ( ECG ) , serum chemistry , hematology , urinalysis . The patient willing able comply study restriction attend regularly schedule clinic visit specify protocol . The patient Mini Mental State Examination ( MMSE ) score 26 screen visit . The patient stable dosage medication ( allow protocol ) minimum 3 month ( selective serotonin reuptake inhibitor [ SSRIs ] serotoninnorepinephrine reuptake inhibitor [ SNRIs ] ) , 8 week ( contraceptive ) , 4 week ( allow medication ) screen visit likely require change therapy least 12 week basis investigator ' assessment . The patient habitual bedtime 2100 2400 . The patient head injury , base medical record documentation history patient reliable informant ( available ) , temporally related onset worsen excessive sleepiness . The patient head injury fulfil criterion TBI within ±1 year TBI identify accord criterion ( a1 ) . The patient history 2 episodes transient loss consciousness ( LOC ) without clear medical explanation , history know suspected pseudo seizure ( psychogenic seizure ) . Patients history seizure epilepsy may eligible follow discussion medical monitor . The patient require , likely require , treatment anticonvulsant medication study , take anticonvulsant medication within 6 month screen visit . The patient unstable uncontrolled medical ( include illness related cardiovascular [ include patient history leave ventricular hypertrophy patient mitral valve prolapse experience mitral valve prolapse syndrome ] , renal , hepatic system surgical ) condition ( treat untreated ) suitable candidate treatment armodafinil , judge investigator . The patient neurosurgery involve brain brainstem . The patient history schizophrenia , bipolar disorder , psychotic depression , psychotic episode . The patient current Axis I disorder ( include depression posttraumatic stress disorder [ PTSD ] ) , assess Structured Clinical Interview Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( SCID ) . The patient Axis II disorder ( assessed SCID ) , opinion investigator , would affect patient participation study full compliance study procedure . The patient history , currently meet The International Classification Sleep Disorders , Edition 2 ( ICSD 2 ) ( American Academy Sleep Medicine 2005 ) criterion narcolepsy , obstructive sleep apnea/hypopnea syndrome ( OSAHS ) , shift work sleep disorder ( SWSD ) , sleep disorder associate excessive daytime sleepiness ; patient history idiopathic hypersomnia , insomnia ( require treatment ) , sleep disorder development TBI . The patient 85 % less sleep efficiency ( sleep duration ÷ time bed x 100 % ) determine nocturnal polysomnography ( NPSG ) . The patient disorder may interfere drug absorption , distribution , metabolism , excretion . The patient use medication , include overthecounter ( OTC ) medicine disallow protocol , within 7 day 5 half life ( medication active metabolite ) , whichever longer , screen visit . The patient need chronic pain medication . In judgment investigator , patient clinically significant deviation normal physical examination . In judgment investigator , patient clinically significant ECG finding . The patient diagnosis type dementia . The patient history suicidal ideation ( consider investigator current clinical significance ) , currently suicidal . The patient know hypersensitivity armodafinil , racemic modafinil , component study drug tablet . Armodafinil tablets contain follow inactive ingredient : croscarmellose sodium , lactose , magnesium stearate , microcrystalline cellulose , povidone , pregelatinized starch . The patient history clinically significant cutaneous drug reaction , history clinically significant hypersensitivity reaction , include multiple allergy drug reaction . The patient clinical laboratory test value ( ) outside range ( ) specify protocol ( clinically significant laboratory abnormality ) , medical monitor provide write approval study participation . The patient history ( within past 5 year ) alcohol , narcotic , drug abuse ( exception nicotine ) define Diagnostic Statistical Manual Mental Disorders American Psychiatric Association , 4th Edition , Text Revision ( DSMIVTR ) , patient current evidence substance use , without medical explanation , confirm result urine drug screen ( UDS ) . The patient take armodafinil , modafinil stimulant medication excessive sleepiness within 1 month screen visit . The patient pregnant lactate woman . ( Any woman become pregnant study withdrawn study . ) The patient know test positive human immunodeficiency virus ( HIV ) . The patient consume average 600 mg caffeine per day , include coffee , tea and/or caffeinecontaining beverage food . The patient use investigational drug within 1 month screen visit . The patient receive workman 's compensation active litigation regard TBI . The patient selfreported Hamilton Depression Rating Scale , 6 Item Version ( S HAM D6 ) score 4 screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>